ICON CLINICAL RESEARCH PROPERTY DEVELOPMENT (IRELAND) LIMITED

Icon Clinical Research Property Development (Ireland) Limited is the Irish arm of ICON plc, a global leader in clinical research and technology solutions. The company partners with biopharma, medical-device developers and health-technology innovators to accelerate drug and therapy development from early-phase studies through market access.

ICON's portfolio spans a wide range of specialised services, including AI-enhanced voice-of-the-customer feedback (EngageAI), bespoke blended solutions for complex sponsor challenges, and outcome-measure frameworks that focus on evidence-based patient benefits. Its biotech offering delivers full-service outsourcing, due-diligence and asset-valuation, while cardiac safety, early clinical and bioanalytical, site-and-patient recruitment, market-access pricing, and specialty laboratory solutions support precision-medicine programmes across all development phases.

In addition to practical services, ICON produces thought-leadership resources such as whitepapers on vaccine follow-up, AI for software-as-a-medical-device, and guidance on ICH GCP E6(R3) implementation, helping clients stay ahead of regulatory and technological change.